Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1265, 2000-01, pp. : 15-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Anastrozole: first-line therapy for advanced breast cancer?
Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. :
Carboplatin: first-line therapy for ovarian cancer?
Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. :
Is There a Growing Role for Endocrine Therapy in the Treatment of Breast Cancer?
By Lønning P.E.
Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. :
Dasatinib: a novel therapy for breast cancer?
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. :
Extend use of adjuvant therapy in breast cancer?
Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. :